Search results
Roche Breast Cancer Medicine to Get Expedited FDA Review
Bloomberg· 4 hours agoRoche Holding AG said an experimental breast-cancer treatment will get an expedited review from US...
Taye Diggs Reveals Sister’s Schizophrenia Diagnosis, Says He’s 'Embarrassed' by His Previous...
People Magazine· 1 hour agoTaye Diggs revealed that his younger sister Christian Diggs, 48, was diagnosed with schizophrenia....
Gaza aid piles up in Egypt, US pier delivery falters
Reuters· 10 hours agoFood and medicine for Palestinians in Gaza are piling up in Egypt because the Rafah crossing remains closed and there has been no aid delivered to a U.N....
EMA recommends suspension of 17-OHPC medicines in EU
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has advised the suspension of marketing authorisations for...
Sponsored Content: HMG Health Matters: Sleep Quality & Overall Well-being
WJHL Tri-Cities via Yahoo News· 2 hours ago(WJHL) Cynthia Dean, FNP and Amy Galloway, FNP, sleep medicine providers talk about quality sleep...
AstraZeneca aims for $80 billion in total revenue by 2030
Reuters via AOL· 8 hours agoAstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday, boosted by...
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Motley Fool via Yahoo Finance· 2 hours agoThat would be a major catalyst for the stock. External developments could have big implications The...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 2 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...
WVU Medicine Health Report: AI Enhanced Endoscopy
WDTV· 16 hours agoIn this edition of the WVU Medicine Health Report, Dr. Shyam Thakkar, Director of WVU Medicine Advanced Endoscopy, talks about how AI can help their...
Is Madrigal Pharmaceuticals Stock a Buy?
Motley Fool via Yahoo Finance· 27 minutes agoMadrigal Pharmaceuticals will focus Rezdiffra's launch on roughly 315,000 NASH patients with moderate to advanced fibrosis who are being seen by...
